FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/12/022214 [Registered on: 02/12/2019] Trial Registered Prospectively
Last Modified On: 27/02/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Comparing different techniques to find out how roomy the nose is to pass a tube through the nose into the windpipe for anaesthesia 
Scientific Title of Study   Comparison of preoperative ultrasonographic technique, preoperative MRI/CT scan imaging and digital examination technique for nostril selection prior to nasotracheal intubation: A randomised controlled trial 
Trial Acronym  USIFOD 
Secondary IDs if Any  
Secondary ID  Identifier 
Trial is not registered with any other registry  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shagun Bhatia Shah  
Designation  Consultant Anaesthesiologist  
Affiliation  Rajiv Gandhi Cancer Institute and Research Centre 
Address  Department of Anaesthesia;Third Floor; Major Operation Theatre Division; Consultants Room;Rajiv Gandhi Cancer Institute and Research Centre Sector-5 ; Rohini ; New Delhi -110085

North West
DELHI
110085
India 
Phone  09891769779  
Fax    
Email  shah.shagun@rgcirc.org  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shagun Bhatia Shah  
Designation  Consultant Anaesthesiologist  
Affiliation  Rajiv Gandhi Cancer Institute and Research Centre 
Address  Department of Anaesthesia;Third Floor; Major Operation Theatre Division; Consultants Room;Rajiv Gandhi Cancer Institute and Research Centre Sector-5 ; Rohini ; New Delhi -110085

North West
DELHI
110085
India 
Phone  09891769779  
Fax    
Email  shah.shagun@rgcirc.org  
 
Details of Contact Person
Public Query
 
Name  Dr Shagun Bhatia Shah  
Designation  Consultant Anaesthesiologist  
Affiliation  Rajiv Gandhi Cancer Institute and Research Centre 
Address  Department of Anaesthesia;Third Floor; Major Operation Theatre Division; Consultants Room;Rajiv Gandhi Cancer Institute and Research Centre Sector-5 ; Rohini ; New Delhi -110085

North West
DELHI
110085
India 
Phone  09891769779  
Fax    
Email  shah.shagun@rgcirc.org  
 
Source of Monetary or Material Support  
Rajiv Gandhi Cancer Institute and research Centre; Sector -5; Rohini; Delhi-110085 
 
Primary Sponsor  
Name  Dr Shagun Bhatia Shah  
Address  H.No-174-175; ground floor ;pocket -17; sector-24; Rohini- Delhi-110085  
Type of Sponsor  Other [Principal Investigator] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shagun Bhatia Shah  Rajiv Gandhi Cancer Institute and Research Centre   Operation Theatre no:6;Department of Anaesthesia;Operation Theatre Division;Third Floor ;Old Building;Sect or-5;Rohini;Delhi-11008 5
North West
DELHI 
9891769779

shah.shagun@rgcirc.org 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Review Board of Rajiv Gandhi Cancer Institute and Research Centre   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C109||Malignant neoplasm of oropharynx,unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Digital examination  Palpation of nostrils with gloved lubricated index finger Frequency: Once 1 min before induction 
Intervention  Fibreoptic bronchoscopic examination  Flexible fibreoptic bronchoscopic examination of the nasal cavity in the operation theatre Frequency: Once One min after induction 
Intervention  Magnetic resonance imaging scan  Display and scrutiny of pre-existing magnetic resonance imaging plates of the nasal region in the view box of the operation theatre Frequency: Once 3 min before induction 
Intervention  Ultrasonographic examination of nose  Point of care ultrasound examination of nostrils Frequency:Once 2 min before induction 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Weight 40-80kg
Patients scheduled to undergo nasotracheal intubation for head and neck oncosurgery
 
 
ExclusionCriteria 
Details  Patient refusal
Pre-existing coagulopathy
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Ease of introduction of nasotracheal tube into the selected nostril  At the time of nasotracheal intubation 
 
Secondary Outcome  
Outcome  TimePoints 
Number of intubation attempts  At the time of nasotracheal intubation 
Bleeding and trauma  At the time of nasotracheal intubation 
Use of smaller sized nasotracheal tube  At the time of nasotracheal intubation 
Endotracheal tube cuff rupture  Immediately after nasotracheal tube insertion on cuff inflation 
Ease of nasogastric tube insertion  At the time of nasogastric tube insertion (1 min after nasotracheal tube insertion) 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/12/2019 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is a prospective, interventional, four-arm, single centric randomised controlled study comparing the ease of intubation between four techniques of determining nasal patency in 120 patients undergoing head and neck oncosurgery requiring nasal intubation. The patients shall be randomly allocated into one of the four groups (Group D: Digital group; Group I: Imaging group; Group S: Sonography group and Group F: Fiberoptic bronchoscopy group).  The primary outcome measures would be ease of nasotracheal tube insertion through the selected nostril into the oral cavity. The secondary outcome measures pertaining to the nasotracheal tube would be the number of attempts at intubation, use of a smaller sized endotracheal tube and complications like bleeding/ tissue trauma and endotracheal tube cuff rupture noted immediately after nasotracheal intubation. Another secondary outcome measure would be the ease of nasogastric tube insertion. 
Close